CDX2 as a Prognostic Biomarker in Colon Cancer REPLY

被引：0

作者：

Dalerba, Piero ^{[1
]}

Sahoo, Debashis ^{[2
]}

Clarke, Michael F. ^{[3
]}

机构：

[1] Columbia Univ, New York, NY USA

[2] Univ Calif San Diego, San Diego, CA 92103 USA

[3] Stanford Univ, Stanford, CA 94305 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 22期

关键词：

COLORECTAL-CANCER; EXPRESSION;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2184 / 2184

页数：1

共 50 条

[21] CDX2 inducible microRNAs sustain colon cancer by targeting multiple DNA damage response pathway factors [J].

Priya, Swati ;

Kaur, Ekjot ;

Kulshrestha, Swati ;

Pandit, Awadhesh ;

Gross, Isabelle ;

Kumar, Nitin ;

Agarwal, Himanshi ;

Khan, Aamir ;

Shyam, Radhey ;

Bhagat, Prakash ;

Prabhu, Jyothi S. ;

Nagarajan, Perumal ;

Deo, S. V. S. ;

Bajaj, Avinash ;

Freund, Jean-Noel ;

Mukhopadhyay, Arnab ;

Sengupta, Sagar .

JOURNAL OF CELL SCIENCE, 2021, 134 (15)

[22] Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer [J].

Xu, Weimin ;

Zhu, Yilian ;

Shen, Wei ;

Ding, Wenjun ;

Wu, Tingyu ;

Guo, Yuegui ;

Chen, Xiaobing ;

Zhou, Mingxia ;

Chen, Yingwei ;

Cui, Long ;

Du, Peng .

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (05) :1829-1842

[23] Prognostic significance of CDX2 immunoexpression in poorly differentiated clusters of colorectal carcinoma [J].

Bonetti, Luca Reggiani ;

Lionti, Simona ;

Vitarelli, Enrica ;

Barresi, Valeria .

VIRCHOWS ARCHIV, 2017, 471 (06) :731-741

[24] Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo [J].

Zheng, Jianbao ;

He, Sai ;

Qi, Jie ;

Wang, Xiaolong ;

Yu, Junhui ;

Wu, Yunhua ;

Gao, Qi ;

Wang, Kai ;

Sun, Xuejun .

INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 51 (02) :478-488

[25] Primary adenocarcinoma of colon: A clinicopathological study with the prevalence and correlation of CDX2 biomarker expression - A tertiary care center experience [J].

Issac, Rijo ;

Masih, Dipti ;

Ranjan, Mark ;

Pulimood, Anna B. .

INDIAN JOURNAL OF CANCER, 2024, 61 (02) :238-243

[26] Reactivation of CDX2 in Gastric Cancer as Mark for Gene Silencing Memory [J].

Kameoka, Yuri ;

Kitazawa, Riko ;

Ariasu, Kanazu ;

Tachibana, Ryosuke ;

Mizuno, Yosuke ;

Haraguchi, Ryuma ;

Kitazawa, Sohei .

ACTA HISTOCHEMICA ET CYTOCHEMICA, 2015, 48 (04) :115-124

[27] CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup [J].

Aasebo, Kristine ;

Dragomir, Anca ;

Sundstrom, Magnus ;

Mezheyeuski, Artur ;

Edqvist, Per-Henrik ;

Eide, Geir Egil ;

Ponten, Fredrik ;

Pfeiffer, Per ;

Glimelius, Bengt ;

Sorbye, Halfdan .

FRONTIERS IN ONCOLOGY, 2020, 10

[28] Regulation of APC and AXIN2 expression by intestinal tumor suppressor CDX2 in colon cancer cells [J].

Olsen, Anders Kruger ;

Coskun, Mehmet ;

Bzorek, Michael ;

Kristensen, Michael Holmsgaard ;

Danielsen, Erik Thomas ;

Jorgensen, Steffen ;

Olsen, Jorgen ;

Engel, Ulla ;

Holck, Susanne ;

Troelsen, Jesper Thorvald .

CARCINOGENESIS, 2013, 34 (06) :1361-1369

[29] CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway [J].

Graule, Janina ;

Uth, Kristin ;

Fischer, Elia ;

Centeno, Irene ;

Galvan, Jose A. ;

Eichmann, Micha ;

Rau, Tilman T. ;

Langer, Rupert ;

Dawson, Heather ;

Nitsche, Ulrich ;

Traeger, Peter ;

Berger, Martin D. ;

Schnuriger, Beat ;

Hadrich, Marion ;

Studer, Peter ;

Inderbitzin, Daniel ;

Lugli, Alessandro ;

Tschan, Mario P. ;

Zlobec, Inti .

CLINICAL EPIGENETICS, 2018, 10 :120

[30] CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer [J].

Wang, Yun-shuai ;

Kou, Yu ;

Zhu, Ren-tao ;

Han, Bao-wei ;

Li, Chao-hui ;

Wang, Huang-jian ;

Wu, Hui-bin ;

Xia, Tian-ming ;

Che, Xiang-ming .

DISEASE MARKERS, 2022, 2022

← 1 2 3 4 5 →